The term Schizophrenia stemming from the combination of the German schizien, meaning “to split,” and phren from the Greek root meaning “mind” the affliction is believed to be categorized by general primarily by disorganized thought methodology, lack of harmonious link between thought and emotion, and an autistic preoccupation propagating a separation from reality. The clinical view of Schizophrenia classify symptoms according to the current DSM -IV TR delusions, hallucinations, disorganized speech, disorganized and catatonic behavior, and negative symptoms synergistically culminating to from the psychotic disorder. Recent publications of clinical trials implicate validity of a negative correlation between cannabis use and Schizophrenia, suggesting cannabis use promotes symptom depression in schizophrenics. On the contrary, conflicting publications perpetuate the premise of cannabis use as predisposition to latter development of schizophrenia.
The relationship between cannabis and schizophrenia is of interest from two perspectives. First, studies based on the self-report of the subjective effects suggest cannabis use in the presence of Schizophrenia mediates symptoms and promotes normalized functionality. Second, cannabis is one of the most used or misused substances with a prevalence of up to 20 percent of people within the age range 14 -21 have used cannabis regularly or heavily. According to the consensus of the analysis 35 studies by Dr. Stanley Zammit in the School of Medicine’s Department of the Psychological Medicine and the colleagues at the University of Bristol, Cambridge and Imperial College the relationship assessment promoted a consistent association to a casual relationship of psychotic disorders. Which may include but it not certainly limited to schizophrenia. A publication of the exploration of cannabis and Schizophrenia entitled Delta-9-Tetrahydrocannabinol Effects in Schizophrenia: Implications for Cognition Psychosis and Addiction...